CDH1 and gastroesophageal reflux disease: In a recently submitted work, we found that amprenavir abrogates epithelial cell disruption, E-cadherin cleavage, and MMP dysregulation by pepsin pH4 in laryngeal cells, supporting the potential utility of amprenavir for both GERD and LPR [38].